Ascidian Therapeutics
Carrie Brockway Wager has held various leadership positions in prominent companies such as Ascidian Therapeutics, Limelight Bio, and Pfizer. With a background in Chemistry and an MBA from MIT Sloan School of Management, Carrie has a proven track record of driving strategic and scientific operations within the pharmaceutical and biotech industry. Carrie's expertise lies in business planning, medical strategy, and business development, making their a valuable asset in the field of oncology and neuroscience research. Carrie currently serves on the MIT Sloan Alumni Board and the Miami University Alumni Advisory Board, showcasing their commitment to giving back to their alma maters.
This person is not in any offices
Ascidian Therapeutics
2 followers
Gene therapy is entering a new era as the field moves forward. But current technologies cannot overcome the challenges of many diseases. Ascidian’s unique approach aims to unlock these doors and enable treatment for millions of patients worldwide.